Athanasios G. Galanopoulos

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Reply to Dr Kemal Örnek Regarding Comments on: "Compound Heterozygosity for the C6777T Mutation of the MTHFR Gene and the FII G20210A Mutation of the Prothrombin Gene in Sequential Bilateral Anterior Ischemic Optic Neuropathy".

Reply to Dr Kemal Örnek Regarding Comments on: "Compound Heterozygosity for the C6777T Mutation of the MTHFR Gene and the FII G20210A Mutation of the Prothrombin Gene in Sequential Bilateral Anterior Ischemic Optic Neuropathy".

Journal: Neuro-ophthalmology (Aeolus Press)

Published: March 23, 2026

Deciphering the role of HMGA2 and let-7 microRNAs in myelodysplastic neoplasms with bone marrow fibrosis.

Deciphering the role of HMGA2 and let-7 microRNAs in myelodysplastic neoplasms with bone marrow fibrosis.

Journal: Leukemia & lymphoma

Published: February 24, 2026

Νοvel Therapies in High-Risk Myelodysplastic Syndromes.

Νοvel Therapies in High-Risk Myelodysplastic Syndromes.

Journal: European journal of haematology

Published: November 23, 2025

Compound Heterozygosity for the C6777T Mutation of the MTHFR Gene and the FII G20210A Mutation of the Prothrombin Gene in Sequential Bilateral Anterior Ischemic Optic Neuropathy.

Compound Heterozygosity for the C6777T Mutation of the MTHFR Gene and the FII G20210A Mutation of the Prothrombin Gene in Sequential Bilateral Anterior Ischemic Optic Neuropathy.

Journal: Neuro-ophthalmology (Aeolus Press)

Published: April 07, 2025

Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS).

Lenalidomide Efficacy in Patients with MDS and Del-5q: Real-World Data from the Hellenic (Greek) National Myelodysplastic & Hypoplastic Syndromes Registry (EAKMYS).

Journal: Cancers

Published: February 28, 2025

Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.

Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.

Journal: British journal of haematology

Published: January 17, 2025

Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients' outcome?

Evaluation of complete response to azacitidine according to the revised International Working Group 2023 response criteria for higher risk MDS. Does it make a difference in patients' outcome?

Journal: Leukemia

Published: July 21, 2023

Increased age-associated B cells in patients with acquired aplastic anemia correlate with IFN-γ.

Increased age-associated B cells in patients with acquired aplastic anemia correlate with IFN-γ.

Journal: Blood advances

Published: March 02, 2023

The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms.

The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms.

Journal: American journal of hematology

Published: January 16, 2023

Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries.

Myelodysplastic neoplasm with isolated thrombocytopenia and immune thrombocytopenic purpura in adults: insights from a comparison of two national registries.

Journal: Leukemia

Published: September 04, 2022

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.

Journal: Annals of hematology

Published: May 06, 2022

Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD).

Residual cognitive and psychosocial functional impairment in outpatients in Greece who responded to conventional antidepressant monotherapy treatments for major depressive disorder (MDD).

Journal: Journal of affective disorders

Published: April 12, 2022

Showing 1-12 of 44

Last Updated: 09/26/2026